Targeting SOAT1 to Rewire Fatty Acid Metabolism and Enhance Immune Response in Hepatocellular Carcinoma
Inhibiting sterol O-acyltransferase 1 (SOAT1) disrupts lipid metabolism and enhances immune activation in hepatocellular carcinoma, offering a promising therapeutic strategy, particularly when combined with PD-1 checkpoint blockade.
